Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.3110
+0.0168 (5.71%)
Nov 17, 2026, 9:32 AM EST - Market open

Bone Biologics Statistics

Total Valuation

Bone Biologics has a market cap or net worth of $1.05 million. The enterprise value is -$5.03 million.

Market Cap1.05M
Enterprise Value -5.03M

Important Dates

The last earnings date was Monday, October 26, 2026, after market close.

Earnings Date Oct 26, 2026
Ex-Dividend Date n/a

Share Statistics

Bone Biologics has 3.39 million shares outstanding. The number of shares has increased by 176.02% in one year.

Current Share Class 3.39M
Shares Outstanding 3.39M
Shares Change (YoY) +176.02%
Shares Change (QoQ) +108.00%
Owned by Insiders (%) 0.02%
Owned by Institutions (%) 6.33%
Float 3.39M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.17
P/TBV Ratio 0.17
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.38, with zero debt.

Current Ratio 13.38
Quick Ratio 12.68
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -47.49% and return on invested capital (ROIC) is -31.46%.

Return on Equity (ROE) -47.49%
Return on Assets (ROA) -29.46%
Return on Invested Capital (ROIC) -31.46%
Return on Capital Employed (ROCE) -50.62%
Weighted Average Cost of Capital (WACC) 9.19%
Revenue Per Employee n/a
Profits Per Employee -$1.42M
Employee Count2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.61% in the last 52 weeks. The beta is 0.90, so Bone Biologics's price volatility has been lower than the market average.

Beta (5Y) 0.90
52-Week Price Change -81.61%
50-Day Moving Average 0.44
200-Day Moving Average 0.99
Relative Strength Index (RSI) 32.36
Average Volume (20 Days) 457,335

Short Selling Information

The latest short interest is 17,632, so 0.52% of the outstanding shares have been sold short.

Short Interest 17,632
Short Previous Month 22,777
Short % of Shares Out 0.52%
Short % of Float 0.52%
Short Ratio (days to cover) 0.47

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -3.01M
Pretax Income -2.84M
Net Income -2.84M
EBITDA n/a
EBIT -3.01M
Earnings Per Share (EPS) -$1.24
Full Income Statement

Balance Sheet

The company has $6.09 million in cash and no debt, with a net cash position of $6.09 million or $1.80 per share.

Cash & Cash Equivalents 6.09M
Total Debt n/a
Net Cash 6.09M
Net Cash Per Share $1.80
Equity (Book Value) 5.95M
Book Value Per Share 1.76
Working Capital 5.95M
Full Balance Sheet

Cash Flow

Operating Cash Flow -2.57M
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing n/a
Free Cash Flow -2.57M
FCF Per Share -$0.76
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Bone Biologics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -176.02%
Shareholder Yield -176.02%
Earnings Yield -399.98%
FCF Yield -257.73%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on June 10, 2025. It was a reverse split with a ratio of 1:6.

Last Split Date Jun 10, 2025
Split Type Reverse
Split Ratio 1:6

Scores

Altman Z-Score n/a
Piotroski F-Score 1